Press release
Emphysema Treatment Market to Reach $8.7 Billion by 2032 Amid Rising Global Health Concerns
Emphysema Treatment Market
Request Sample of the Report on Emphysema Treatment Market Forecast - https://www.alliedmarketresearch.com/request-sample/A14372
🔍 Key Market Drivers
Rising prevalence of emphysema due to smoking and air pollution.
Early diagnosis rates improving, especially in developing nations.
Growing preference for homecare treatments, such as portable oxygen therapy.
Asia-Pacific witnessing rapid growth due to government healthcare initiatives and rising environmental concerns.
📉 Impact of 2023 Global Recession
Temporary slowdown in R&D investments and reduced hospital spending.
However, long-term demand remains strong as emphysema cases continue to grow, pushing healthcare systems to adapt.
📊 Market Segmentation Insights
By Treatment Type (2022 Snapshot)
Medications (75% share): Includes bronchodilators and corticosteroids.
Oxygen therapy and surgical interventions also gaining traction.
By Emphysema Type
Centriacinar emphysema (50% share): Most prevalent due to smoking.
Panacinar and mixed types: Expected to grow with better diagnostic capabilities.
By End User
Homecare segment (40% share): Boosted by portable and user-friendly devices.
Hospitals and specialty respiratory centers remain essential for complex cases.
🌍 Regional Highlights
North America leads with 40% market share, driven by strong R&D, healthcare infrastructure, and early adoption of new treatments.
Asia-Pacific expected to record the highest CAGR, fueled by rising pollution levels, increasing patient awareness, and healthcare investments.
🏥 Competitive Landscape
Key players shaping the global market:
AstraZeneca
Boehringer Ingelheim
GlaxoSmithKline (GSK)
Novartis
Teva Pharmaceuticals
Koninklijke Philips N.V. (notable for portable oxygen solutions)
Strategic collaborations, new product development, and clinical trials remain central to competitive positioning in the market.
🔮 Future Outlook
Rising global burden of respiratory diseases will fuel demand for effective, cost-efficient treatments.
Innovations in targeted therapy and homecare devices will revolutionize patient management.
Asia-Pacific poised to be the next growth frontier due to a convergence of policy support, urbanization, and demographic trends.
📘 Want to learn more?
For a deep dive into market dynamics, investment trends, and strategic opportunities, download the full Allied Market Research report today: https://www.alliedmarketresearch.com/emphysema-treatment-market-A14372
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
Davin Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com
Follow Us on | Facebook | LinkedIn | YouTube |
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emphysema Treatment Market to Reach $8.7 Billion by 2032 Amid Rising Global Health Concerns here
News-ID: 4045976 • Views: …
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for Emphysema
Emphysema Market: A Comprehensive Overview
Emphysema is a chronic lung disease that primarily affects the alveoli, or air sacs, in the lungs. It is one of the key components of chronic obstructive pulmonary disease (COPD), characterized by progressive difficulty in breathing due to damage to the air sacs, leading to reduced oxygen exchange. The global burden of emphysema is increasing, with more people being diagnosed as the aging population grows and environmental factors like smoking…
Emphysema Treatment Market Overview 2024-2033 - Share, Trends, Demand, Outlook
"The new report published by The Business Research Company, titled ""Emphysema Treatment Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp
Surging Cases Of Chronic Obstructive Pulmonary Disease (COPD) To Drive Market Growth
The rise in the prevalence…
Emphysema Market: Global Industry Analysis and Forecast (2024-2030)
Emphysema Market to Hit USD 6.32 Bn at a growth rate of 4.28 percent- Says Stellar Market Research
The Emphysema Market size of the North America region is expected to dominate the market during the forecast period. The Emphysema Market is segmented into By Type, By Treatment, and By Distribution Channel for a better understanding of the market structure.
Stellar Market Research, a Healthcare business consultancy and research firm has published…
Navigating the Emphysema Treatment Market: Growth, Trends, and Size
Emphysema is a chronic obstructive pulmonary disease (COPD) characterized by the progressive destruction of the air sacs in the lungs, leading to reduced lung function and severe breathing difficulties. This condition is primarily caused by long-term exposure to irritants such as tobacco smoke, air pollution, and occupational dust and chemicals. As a result, the emphysema treatment market has emerged as a critical component of respiratory healthcare.
Emphysema patients experience symptoms like…
Emphysema Drug Market Will Generate Record Revenue by 2029
The Emphysema Drug Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2023-2029). Emphysema is also referred as chronic obstructive disorder because inhalation and exhalation are slowed down due to over inflammation of alveoli. Emphysema can cause damage to air sac which results in change of shape of air sac or often destruction resulting in low gas exchanged in the lungs leading…
Worldwide Emphysema Market 2018 | Emphysema cases are High in Middle East, China …
Emphysema, a lung disease is characterized by the shortness of breath, thereby, damaging the air sacs in the lungs. The disease leads to rupture and weakening of inner walls of the air sacs over the period. The disease involves the reduction in the surface area of the lungs which in turn reduces the amount of oxygen reaching the bloodstream. Hence, during exhalation, the alveoli do not function properly leaving the…
